Clinical Trials Directory

Trials / Unknown

UnknownNCT06208930

The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10,000 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The exploration of the safety and efficacy of fecal microbiota transplantation in the treatment of non-digestive system diseases associated with gastrointestinal symptoms in the gastrointestinal tract, while also investigating the impact of fecal microbiota transplantation on the intestinal system, and assessing the improvement of symptoms in other systems.Simultaneously optimizing the conditions during the FMT process, identifying the most effective treatment methods to enhance the therapeutic outcomes of FMT.

Conditions

Interventions

TypeNameDescription
PROCEDUREFecal microbiota transplantationFecal microbiota transplantation (FMT) is a method for treating imbalances in the intestinal microbiota. Its basic principle involves extracting a portion of feces from a healthy individual that contains a diverse population of beneficial bacteria, processing it, and transplanting it into the digestive system of the recipient to restore a balanced intestinal microbiota.

Timeline

Start date
2018-01-10
Primary completion
2025-12-10
Completion
2025-12-10
First posted
2024-01-17
Last updated
2024-01-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06208930. Inclusion in this directory is not an endorsement.